Back

Hepcidin and cardiovascular events in patients with chronic kidney disease undergoing dialysis: a post-hoc analysis of the ASCEND-D trial

1 September 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Risk scores in cardio-oncology Stratification, Prevention and Monitoring ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Yudai Fujimoto

University Medical Centre Groningen, Groningen (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Assessment of ESC risk stratification for cancer therapy-related cardiovascular toxicity in a real-world urban population
Doctor J. Arnold (Chicago, US)
Abstract Slides
Presentation thumbnail
Accurate and efficient cardio-oncology outpatient clinic summarization with open-source large language models for non-english text
Doctor J. Heemelaar (Leiderdorp, NL)
Abstract Slides
Presentation thumbnail
Systemic H-FABP, hs-cTnT, hs-CRP and Monocyte-to-Lymphocyte ratio were significantly reduced by sacubitril/valsartan in doxorubicin-treated preclinical models through NLRP3-mTOR-AKT pathways
Doctor N. Maurea (Naples, IT)
Abstract Slides
Presentation thumbnail
The new mechanism of apatinib in treating gastric cancer-related hypertension: dynamin-related protein 1-mediated pathological mitochondrial fission in endothelial cells
Doctor F. Si (Lanzhou, CN)
Abstract Slides
Presentation thumbnail
The diagnostic and prognostic value of high-sensitivity troponin T for cardiovascular outcomes in patients receiving immune checkpoint inhibitor therapy.
Associate Professor C. Ayoub (Phoenix, US)
Abstract Slides

Access the full session

Session thumbnail
Risk scores in cardio-oncology

The Event

Event poster

ESC Congress 2025

1 September 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Inflammatory marker C-reactive protein and the iron metabolism regulator hepcidin in elderly and senile patients with chronic heart failure and anemia of chronic disease
29 June 2021
thumbnail
Congress Presentation
Mortality after implantable cardioverter defibrillators in dialysis patients: a nationwide study
1 September 2020
thumbnail
Congress Presentation
Effect of finerenone in patients with chronic kidney disease and type 2 diabetes by baseline anaemia status: a FIDELITY analysis
28 August 2023
thumbnail
Congress Presentation
High-sensitivity C-Reactive protein predicts post-percutaneous coronary intervention cardiovascular risk with CKD status effect: evidence from a prospective registry study
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources